• 4750 Citations
  • 37 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer

Kim, E. K., Kim, K. A., Lee, C. Y., Kim, S., Chang, S., Cho, B. & Shim, H. S., 2019 Jan 1, In : Clinical Lung Cancer. 20, 1, p. e123-e132

Research output: Contribution to journalArticle

Molecular Pathology
Non-Small Cell Lung Carcinoma
Exons
Mutation
Reverse Transcription

Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models

Pyo, K. H., Kim, J. H., Lee, J. M., Kim, S. E., Cho, J. S., Lim, S. M. & Cho, B., 2019 Jan 1, In : Lung Cancer. 127, p. 112-121 10 p.

Research output: Contribution to journalArticle

Immunotherapy
Lung Neoplasms
Pharmaceutical Preparations
Neoplasms
Cytokines
2 Citations

A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer

Park, Y. M., Keum, K. C., Kim, H. R., Cho, B., Kim, D. H., Cho, N. & Kim, S. H., 2018 Apr 1, In : Annals of surgical oncology. 25, 4, p. 864-871 8 p.

Research output: Contribution to journalArticle

Hypopharyngeal Neoplasms
Robotics
Combination Drug Therapy
Clinical Trials
Survival Rate
11 Citations

Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies

Lim, S. M., Syn, N. L., Cho, B. C. & Soo, R. A., 2018 Apr 1, In : Cancer Treatment Reviews. 65, p. 1-10 10 p.

Research output: Contribution to journalReview article

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Therapeutics
Mutation
1 Citations

Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea

Choi, M. K., Ahn, J. S., Kim, Y. C., Cho, B., Oh, I. J., Kim, S. W., Lee, J. S., Kim, J. H., Ahn, M. J. & Park, K., 2018 May 1, In : Lung Cancer. 119, p. 36-41 6 p.

Research output: Contribution to journalArticle

Compassionate Use Trials
Korea
Non-Small Cell Lung Carcinoma
Epidermal Growth Factor Receptor
Treatment Failure